Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome Read more about Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU) Read more about A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation Read more about DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation
Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) Read more about Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer Read more about Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer
Low Energy Dissection Vs. Electrocautery in Lumpectomy Shaved Surgical Margins Read more about Low Energy Dissection Vs. Electrocautery in Lumpectomy Shaved Surgical Margins
Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer Read more about Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433 Read more about A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433